BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9272330)

  • 1. Pertussis: a worldwide problem.
    Ivanoff B; Robertson SE
    Dev Biol Stand; 1997; 89():3-13. PubMed ID: 9272330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of pertussis in the world.
    Galazka A
    World Health Stat Q; 1992; 45(2-3):238-47. PubMed ID: 1462658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can we control pertussis better? I. Changes in the epidemiology of pertussis].
    Gałazka A
    Przegl Epidemiol; 1997; 51(3):275-84. PubMed ID: 9411498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current epidemiology of pertussis in the United States.
    Hutchins SS; Cochi SL; Brink EW; Patriarca PA; Wassilak SG; Rovira EZ; Hinman AR
    Tokai J Exp Clin Med; 1988; 13 Suppl():103-9. PubMed ID: 2856218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology of pertussis in industrialized countries].
    Baron S; Bégué P; Grimprel E
    Sante; 1994; 4(3):195-200. PubMed ID: 7921686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age at pertussis immunization as it relates to current epidemiology and disease control.
    Funkhouser AW; Wassilak SG; Hinman AR; Orenstein WA; Mortimer EA
    Tokai J Exp Clin Med; 1988; 13 Suppl():111-5. PubMed ID: 3273610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Time for booster doses against whooping cough for 10-year-old children].
    Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
    Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
    Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
    Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of children with diagnosed pertussis].
    Kardas-Sobantka D; Golebiowska M; Libich M; Stryjewska I
    Przegl Epidemiol; 2000; 54(3-4):357-65. PubMed ID: 11349599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pertussis--United States, 1997-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(4):73-6. PubMed ID: 11837909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis notifications in Australia, 1991 to 1997.
    Andrews R; Herceg A; Roberts C
    Commun Dis Intell; 1997 May; 21(11):145-8. PubMed ID: 9188218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 1993 epidemic of pertussis in Cincinnati. Resurgence of disease in a highly immunized population of children.
    Christie CD; Marx ML; Marchant CD; Reising SF
    N Engl J Med; 1994 Jul; 331(1):16-21. PubMed ID: 8202096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boostrix: a reduced-dose acellular pertussis vaccine for use in adolescents and adults.
    Li WC; Wu TZ; Huang YC; Huang LM
    Expert Rev Vaccines; 2009 Oct; 8(10):1317-27. PubMed ID: 19803753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis in Poland.
    Gzyl A; Augustynowicz E; Rabczenko D; Gniadek G; Slusarczyk J
    Int J Epidemiol; 2004 Apr; 33(2):358-65. PubMed ID: 15082640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of pertussis.
    Tan T; Trindade E; Skowronski D
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S10-8. PubMed ID: 15876918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.